SHANGHAI NO.1 PHARMACY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.2 CNY | -.--% |
|
+0.27% | -6.82% |
| Sales 2022 | 2.66B 367M 29.44B | Sales 2023 | 1.82B 251M 20.17B | Capitalization | 2.68B 370M 29.72B |
|---|---|---|---|---|---|
| Net income 2022 | 144M 19.89M 1.6B | Net income 2023 | 89M 12.29M 986M | EV / Sales 2022 | 0.83 x |
| Net cash position 2022 | 308M 42.48M 3.41B | Net cash position 2023 | 230M 31.75M 2.55B | EV / Sales 2023 | 1.35 x |
| P/E ratio 2022 |
17.6
x | P/E ratio 2023 |
30.1
x | Employees | 870 |
| Yield 2022 |
1.73% | Yield 2023 |
1.04% | Free-Float | 45.02% |
More Fundamentals
* Assessed data
More news
| 1 week | +0.27% | ||
| Current month | -0.44% | ||
| 1 month | -0.44% | ||
| 3 months | -0.36% | ||
| 6 months | +2.56% | ||
| Current year | -6.82% |
1 week
10.93
11.39
1 month
10.3011.96
Current year
7.9112.31
1 year
7.9114.91
3 years
7.6915.85
5 years
7.6915.85
10 years
7.1738.65
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Yao
CEO | Chief Executive Officer | 51 | 04/01/23 |
Hai Bo Zhang
CHM | Chairman | 45 | 29/03/21 |
Zheng Sun
DFI | Director of Finance/CFO | 50 | 18/09/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Pei Cheng
BRD | Director/Board Member | 61 | 25/06/18 |
Feng Li
CHM | Chairman | 53 | 14/10/20 |
Hai Bo Zhang
CHM | Chairman | 45 | 29/03/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 11.2 | -.--% | 3,618,400 |
| 29/04/24 | 11.2 | +0.09% | 2,663,302 |
| 26/04/24 | 11.19 | +0.45% | 3,437,500 |
| 25/04/24 | 11.14 | -0.62% | 2,000,301 |
| 24/04/24 | 11.21 | +0.27% | 1,888,400 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes
Shanghai No.1 Pharmacy Co Ltd is a China-based company primarily engaged in the retail and wholesale business of pharmaceuticals. The retail business model mainly purchases medicines, food, medical equipment, health convenience products and other commodities from upstream suppliers, and then retails them to end consumers. The wholesale business model mainly purchases medicines and other commodities from upstream suppliers and then sells them to terminal medical institutions or other pharmaceutical and other commodity circulation companies.
Sector
Drug Retailers
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -6.82% | 345M | |
| -10.56% | 3.66B | |
| -0.49% | 3.41B | |
| -23.53% | 3.08B | |
| +11.98% | 2.7B | |
| +6.87% | 2.67B | |
| -10.98% | 1.77B | |
| +11.58% | 1.37B | |
| -19.60% | 970M | |
| -37.98% | 710M |
- Stock Market
- Equities
- 600833 Stock
